MSD Czech Republic
Buying intent
34 tracked signals | Top 15 topics are below | Engineering and Marketing are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere MSD Czech Republic's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
18d ago
2d ago
18d ago
17d ago
27d ago
17d ago
18d ago
19d ago
18d ago
17d ago
22d ago
27d ago
22d ago
9d ago
27d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at MSD Czech Republic
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileAt MSD, we harness the power of leading-edge science to save and improve lives globally. Our mission is to develop transformative therapies and vaccines that address some of the world’s most challenging health issues, including oncology, immunology, diabetology, infectious diseases, and cardiometabolic disorders. Established in 2014, MSD Czech Republic focuses on both human and animal health
Top accounts researching MSD Czech Republic
names withheld on the public pageThese are companies whose own people brought up MSD Czech Republic unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
75,708 companies · 411,263 people are researching Hiring
MSD Czech Republic's own team shows 8 signals on this topic. No one outside MSD Czech Republic has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Artificial Intelligence151,426 cos · 839,012 people
- Agentic AI System32,339 cos · 130,942 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)IT — 2 people; Security — 1 person; Marketing — 1 person; Engineering — 1 person; Finance — 1 person; Data / Analytics — 1 person
What's been said
public posts by MSD Czech Republic's teamNo public post naming MSD Czech Republic has surfaced in the past year, so this is what MSD Czech Republic's own team is posting about publicly — their topics, in their words.
48 hours, 15 teams, and a 97% accuracy rate.🏆 I recently attended the Europe Tech Hackathon 2026 in Vienna by ViennaUP, and it was the perfect reminder of what happens when you combine the right tech with the right people. 🇦🇹✨ Our challenge was building an AI application for Trench Analysis. Because 48 hours demands speed, we focused on a fast prototype—building a fully dockerized web application powered by Google's Gemini LLM. The result? We managed to tackle the problem with a 97% accuracy rate. 🧠💻 But the tech only worked because of the team dynamic. We brought together entirely different technical backgrounds, pairing deeply experienced, hardworking engineers with an absolute powerhouse of a presenter who nailed the final pitch. While we didn’t take 1st place out of the 15 competing teams, winning the Best Team Spirit Award felt incredibly fitting. 🏆❤️ Huge credit to the crew who made this sprint successful: • 🛠️ Sara Tesas • 🛠️ Vassil Bakalov • 🛠️ Abigail Llanque Romero • 🛠️ Lene König • 🛠️ Federico Ercole Thanks to Sustainista team and ViennaUP for a fantastic event! #EuropeTechHackathon #ViennaUP #ArtificialIntelligence #GeminiLLM #Docker #DataScience #Hackathon #Innovation #Google #AI
May 2026I had a blast opening the Data in Context Meet Up with a short hook: “Your AI model is only as good as the decision it was never designed to make”. In Biopharma, model accuracy isn't the bottleneck—it’s the gap between an AI output and a human decision. We discussed why "Context is King": A huge thanks to the organizers for the invite and to my fellow panelists Adéla Ráčková Jiří Kacerovský Martin Matějka and panel moderator Ota Novotny for the sharp cross-sector insights. It’s clear that whether you're in Telco, Banking, Fintech or Pharma, the "last mile" from data to action remains our biggest challenge. How do you bridge the gap between data and decisions in your world?
May 2026